[
  {
    "id": "Case1",
    "patient_info": "At 17 weeks\u2019 gestation, the fetus is being evaluated for suspected Hirschsprung disease, with concern first arising in the first trimester; the case was referred by the pregnant patient\u2019s primary care physician, and whole exome sequencing is being pursued to clarify an underlying genetic etiology. Prior Fragile X testing was non-diagnostic. Family history is notable for a maternal aunt who carries a known BRCA1/2 pathogenic variant. Insurance coverage is through UnitedHealthcare (UHC)."
  },
  {
    "id": "Case12",
    "patient_info": "A 51-year-old woman with learning and adaptive difficulties recognized in early childhood and persisting into adulthood, without other syndromic features, was referred by her gynecologist for germline BRCA1 and BRCA2 testing; prior fluorescence in situ hybridization was non-diagnostic. Family history is notable for a younger brother who had significant hearing loss diagnosed in early adolescence. She declined pre-test genetic counseling, with plans to re-offer counseling when results are available. She is insured through UnitedHealthcare under the Choice Plus plan."
  }
]